Thurston Springer Miller Herd & Titak’s 10x Genomics TXG Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$383	Hold	10	–	–	﹤0.01%	1209
2026 Q1	$212	Hold	10	–	–	﹤0.01%	1304
2025 Q4	$163	Buy	+10	New	+$151	﹤0.01%	1348
2025 Q3	–	Sell	-10	Closed	-$115	–	1299
2025 Q2	$115	Hold	10	–	–	﹤0.01%	1618
2025 Q1	$87	Hold	10	–	–	﹤0.01%	1660
2024 Q4	$143	Sell	10 -2	-17%	-$32	﹤0.01%	1312
2024 Q3	$270	Hold	12	–	–	﹤0.01%	1497
2024 Q2	$232	Buy	+12	New	+$314	﹤0.01%	1486

Other funds holding TXG

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $816M AUM 42.46% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Empirical Wealth Management Seattle, Washington $6.82B AUM 30.02% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Tactive Advisors Jacksonville, Florida $406M AUM 35.68% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

Regent Peak Wealth Advisors Atlanta, Georgia $540M AUM 26.3% 1-Year Est. Return